Research libraryMOLEKUL / SOURCE RECORD

Effects of vitamin B1/B6/B12 complex on methotrexate-induced hepatorenal toxicity in a short-term acute rat model

Toprak-Semiz A, Deniz E, Topçu A, Mataracı Karakaş S, Öztürk Ç, Yavuz-Bedir E · 2026 · Naunyn-Schmiedeberg's archives of pharmacology

Published 2026-10-13. Indexed 2026-10-19.

Animal / experimentalEnglish abstractSource linked

Reported findings and study design

B1/B6/B12 combinations improved selected biochemical measures after methotrexate exposure. Both doses lowered creatinine and renal TBARS; only the higher dose lowered AST and hepatic TBARS. Neither dose significantly improved liver or kidney histopathology, ALT, urea or total thiol.

Dose, route and schedule

B1/B6/B12 intraperitoneally daily on days 1–14 at 16/16/0.16 or 32/32/0.32 mg/kg; methotrexate 20 mg/kg intraperitoneally once on day 7. Rat study methods; formulation not established as Binavit.

Protocol source ↗ · Indexed abstract checked

Reported findings and study figures · Indexed abstract checked
MeasureResultComparison, timing and statistics
Low vitamin doseB1/B6/B12: 16/16/0.16 mg/kg dailyIntraperitoneal, days 1–14; animal doses
High vitamin doseB1/B6/B12: 32/32/0.32 mg/kg dailyIntraperitoneal, days 1–14; animal doses
Creatinine and renal TBARSLower at both vitamin dosesVersus methotrexate alone
AST and hepatic TBARSLower only at the higher dose
Histopathology, ALT, urea and total thiolNo significant improvement

This is class-level B-vitamin research in rats, not evidence for the Binavit brand or human methotrexate care. No vitamin-only group was included, and biochemical changes were not accompanied by significant tissue-level improvement.

Source for the extracted data ↗ · Checked 2026-10-31

Molekul summary of the linked publication. Educational information, not medical advice. Seek qualified healthcare help for medical conditions.

Methods, limitations & source review

Study limitations

  • This is class-level B-vitamin research in rats, not evidence for the Binavit brand or human methotrexate care. No vitamin-only group was included, and biochemical changes were not accompanied by significant tissue-level improvement.

Publication counts are not counts of independent trials. Reviews, translations and reports sharing participants may overlap. Findings apply to the studied preparation, population and endpoints.

Review depth: Indexed abstract checked

Source access and review scope

Primary publication metadata and indexed abstract checked through Europe PMC on 31 October 2026. No unavailable effect sizes inferred.

Recorded source-check date: 2026-10-31. This date does not imply a completed systematic review.

Source type: Journal publication

Open original source or index record ↗

DOI: 10.1007/s00210-026-05993-4

Citation and original source

Original source: Toprak-Semiz A, Deniz E, Topçu A, Mataracı Karakaş S, Öztürk Ç, Yavuz-Bedir E. Effects of vitamin B1/B6/B12 complex on methotrexate-induced hepatorenal toxicity in a short-term acute rat model Naunyn-Schmiedeberg's archives of pharmacology 2026.

Molekul research summary: https://molekul.io/research/oct31-42864503. Cite the original publication for its findings and this page when referring to Molekul’s summary or evidence appraisal.

Bibliography entry

Related compound profiles

Editorial policy and evidence standards